Intuitive Surgical (NASDAQ:ISRG) announced its earnings results on Thursday. The medical equipment provider reported $3.43 EPS for the quarter, beating analysts’ consensus estimates of $2.99 by $0.44, Bloomberg Earnings reports. The firm had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Intuitive Surgical had a return on equity of 18.77% and a net margin of 30.94%. Intuitive Surgical’s quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.83 EPS.
Shares of Intuitive Surgical stock opened at $566.25 on Friday. Intuitive Surgical has a fifty-two week low of $430.24 and a fifty-two week high of $589.32. The firm has a market cap of $61.02 billion, a PE ratio of 48.08, a P/E/G ratio of 3.89 and a beta of 1.13. The business’s fifty day moving average is $521.84 and its two-hundred day moving average is $517.32.
A number of brokerages have commented on ISRG. Redburn Partners began coverage on Intuitive Surgical in a report on Friday, September 13th. They set a “buy” rating on the stock. Cantor Fitzgerald set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a report on Friday, July 19th. Piper Jaffray Companies increased their target price on Intuitive Surgical from $610.00 to $633.00 and gave the company an “overweight” rating in a report on Friday, July 19th. UBS Group increased their target price on Intuitive Surgical from $560.00 to $590.00 and gave the company a “neutral” rating in a report on Friday. Finally, ValuEngine cut Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Friday, July 12th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $579.08.
In other Intuitive Surgical news, VP Marshall Mohr sold 15,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $526.11, for a total transaction of $7,891,650.00. Following the transaction, the vice president now owns 20,135 shares of the company’s stock, valued at approximately $10,593,224.85. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Curet Myriam sold 4,974 shares of the stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $532.14, for a total value of $2,646,864.36. Following the transaction, the executive vice president now directly owns 3,851 shares in the company, valued at approximately $2,049,271.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,869 shares of company stock worth $13,664,252. Corporate insiders own 1.70% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: Trading Options- What is a Strangle?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.